Moore Capital Management’s Envoy Medical COCH Stock Holding History

Moore Capital Management’s Portfolio COCH Stock Details COCH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-50,000	Closed	-$343K	–	464
2023 Q3	$343K	Hold	50,000	–	–	0.01%	351
2023 Q2	$513K	Hold	50,000	–	–	0.01%	342
2023 Q1	$503K	Sell	50,000 -450,000	-90%	-$4.51M	0.01%	319
2022 Q4	$5.05M	Hold	500,000	–	–	0.12%	152
2022 Q3	$4.92M	Hold	500,000	–	–	0.12%	194
2022 Q2	$4.9M	Hold	500,000	–	–	0.13%	186
2022 Q1	$4.88M	Hold	500,000	–	–	0.12%	203
2021 Q4	$4.88M	Hold	500,000	–	–	0.1%	220
2021 Q3	$4.85M	Hold	500,000	–	–	0.07%	286
2021 Q2	$4.85M	Buy	+500,000	New	+$4.86M	0.07%	291

Other funds holding COCH

AMC

Atlas Merchant Capital New York $789K AUM 60.67% 1-Year Est. Return

Meteora Capital Boca Raton, Florida $1.36B AUM 21.19% 1-Year Est. Return

PAMP

Polar Asset Management Partners Toronto, Ontario, Canada $5.01B AUM 35.27% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

WAM

Weiss Asset Management Boston, Massachusetts $5.91B AUM 42.42% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Moore Capital Management's COCH Position: Q4 2023 in Review

Moore Capital Management sold out of Envoy Medical (COCH) in Q4 2023, closing a stake of 50,000 shares — an estimated $343K sold.

Moore Capital Management first reported a position in COCH in Q2 2021 and held it in 10 quarters. The position peaked at $5.05M in Q4 2022. 9 funds tracked by Wall St. Rank hold COCH as of Q4 2023.

Moore Capital Management reported no remaining Envoy Medical position as of Q4 2023 after selling out during the quarter.
Moore Capital Management sold 50,000 Envoy Medical shares in Q4 2023, an estimated $343K.
Moore Capital Management first reported a position in Envoy Medical in Q2 2021 and held it in 10 quarters.
Moore Capital Management's Envoy Medical position peaked at $5.05M in Q4 2022.
9 funds tracked by Wall St. Rank held Envoy Medical as of Q4 2023.

Based on Moore Capital Management's 13F filing for Q4 2023, filed 14 Feb 2024.